Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Stuart Gall and Nick Rodgers as non-executive directors.

Both executives have considerable C-Suite experience across healthcare and technology companies. Gall is chief executive of Intelligent Ultrasound, an AIM-listed medical imaging company providing ‘classroom to clinic’ ultrasound technologies.

Rodgers is chair of SEHTA, one of the largest health technology membership and networking organisations in the UK supporting businesses in the health technology sector, and was formerly chair of Destiny Pharma, a developer of novel anti-infective products.